Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2023-01-04 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (景岳生物科技股份有限公司) regarding the commitments made when applying for stock listing transfer and the subsequent execution status as of the fourth quarter of 2022. It references compliance with Taiwan Stock Exchange regulations and details about auditor commitments and financial reporting practices. The document is short (843 characters) and primarily serves as a regulatory disclosure about compliance and auditor-related commitments rather than containing financial statements or detailed financial data. It does not present a full financial report, earnings release, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-01-04 Chinese
111年12月21日內部人設質解質
Director's Dealing Classification · 95% confidence The document is a short tabular report showing a pledge of shares by a director's spouse, including details such as company code, name, pledgor identity, pledge date, number of shares pledged, and pledgee. This matches the description of a Director's Dealing report, which covers personal share transactions by company directors and executives. The document length is very short (324 characters), but it contains specific data about share pledging by a director's related party, not just an announcement or a certification. Therefore, it fits best under Director's Dealing (DIRS).
2022-12-23 Chinese
111年12月法人說明會簡報 — 316420221215E001.pdf
Annual Report Classification · 95% confidence The document contains detailed financial data including separate and consolidated financial statements for multiple years, with figures such as net revenue, gross profit, operating expenses, and net income. It also includes extensive business information about the company's market outlook, research, patents, clinical trials, and manufacturing facilities. The presence of comprehensive financial statements and business overview indicates this is a full annual report covering company activity and financial performance. There is no indication that this is merely an announcement or a presentation; the document length and content confirm it is the report itself. Therefore, the document fits the definition of an Annual Report (10-K). 9M 2022
2022-12-15 Chinese
111年12月法人說明會簡報 — 316420221215M001.pdf
Annual Report Classification · 95% confidence The document contains detailed financial data including separate and consolidated financial statements for multiple years, with figures such as net revenue, gross profit, operating expenses, and net income. It also includes extensive business and market information about probiotics, research results, patents, and clinical trials. The presence of comprehensive financial statements and business analysis for the year 2021 and partial 2022 indicates this is a full annual report rather than a brief announcement or presentation. There is no indication that this is merely an announcement of a report or a certification. The document length (9106 characters) and content depth support classification as an Annual Report (10-K). 9M 2022
2022-12-15 Chinese
111年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled investor presentation (法人說明會) including company code, name, date, time, location, and links to presentation materials. It is not a full report but rather an announcement or summary of an investor presentation event. The presence of presentation files and the nature of the content indicate this is an Investor Presentation (IP). The document length is short and focused on the event details, consistent with an investor presentation notice rather than a full report or regulatory filing.
2022-12-15 Chinese
受邀參加永豐金證券舉辦之法人說明會，說明本公司之營運概況
Regulatory Filings Classification · 95% confidence The document is a short announcement (652 characters) about the company being invited to participate in an investor presentation hosted by a securities firm. It provides details such as date, time, location, and a brief description of the event (explaining the company's operational overview). There is no detailed financial data or comprehensive report content. The document is essentially a notice about an upcoming investor presentation event, not the presentation itself or a financial report. According to the classification rules, such announcements fall under Investor Presentation (IP) if they contain the presentation itself, or Regulatory Filings (RNS) if they are just notices. Since this document only announces the event and refers readers to another source for full financial information, it is best classified as a Regulatory Filing (RNS).
2022-12-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.